Stimulating progress in regenerative medicine: Improving the cloning and recovery of cryopreserved human pluripotent stem cells with ROCK inhibitors

Regenerative Medicine

Volumn 5, Issue 5, 2010, Pages 799-807

  Rizzino, Angie ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Accutase ; apoptosis; cloning efficiency; cryopreservation; embryonic stem cell n fasudil; induced pluripotent stem cell; Rho associated coiled coil kinase; Y 27632

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; FASUDIL; NEUROTROPHIC FACTOR; PROTEIN P160; RHO KINASE INHIBITOR;

BIOREACTOR; BIOTECHNOLOGY; CELL CLONING; CELL DENSITY; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL RENEWAL; CELL STRESS; CELL SURVIVAL; CELL SUSPENSION; CELL VIABILITY; CRYOPRESERVATION; CULTURE MEDIUM; CULTURE TECHNIQUE; EMBRYO CELL; FREEZE THAWING; GERM LAYER; HUMAN; HUMAN CELL CULTURE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SEPARATION TECHNIQUE; TISSUE CULTURE; VITRIFICATION;

CLONE CELLS; CRYOPRESERVATION; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; PROTEIN KINASE INHIBITORS; REGENERATIVE MEDICINE; RHO-ASSOCIATED KINASES;

EID: 77957565227     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.10.45     Document Type: Review

References (38)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al.: Embryonic stem cell lines derived from human blastocysts. Science 282(5395), 1145-1147 (1998). •First report demonstrating the isolation of human embryonic stem cells (hESCs).
2. Takahashi K, Tanabe K, Ohnuki M et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5), 861-872 (2007).
3. Wernig M, Meissner A, Foreman R et al.: In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448(7151), 318-324 (2007). (Pubitemid 47080337)
4. Yu J, Vodyanik MA, Smuga-Otto K et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858), 1917-1920 (2007).
5. Kiskinis E, Eggan K: Progress toward the clinical application of patient-specific pluripotent stem cells. J. Clin. Invest. 120(1), 51-59 (2010).
6. Ronaghi M, Erceg S, Moreno-Manzano V, Stojkovic M: Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? Stem Cells 28(1), 93-99 (2010).
7. Krawetz RJ, Li X, Rancourt DE: Human embryonic stem cells: caught between a ROCK inhibitor and a hard place. Bioessays 31(3), 336-343 (2009).
8. Reubinoff BE, Pera MF, Fong C, Trounson A, Bongso A: Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18(4), 399-404 (2000).
9. Buzzard JJ, Gough NM, Crook JM, Colman A: Karyotype of human ES cells during extended culture. Nat. Biotechnol. 22(4), 381-382 (2004).
10. Mitalipova MM, Rao RR, Hoyer DM et al.: Preserving the genetic integrity of human embryonic stem cells. Nat. Biotechnol. 23(1), 19-20 (2005).
11. Trish E, Dimos J, Eggan K: Passaging HuES human embryonic stem cell-lines with trypsin. J. Vis. Exp. 12(1), 49 (2006).
12. Andrews PW: Response letter. Nat. Biotechnol. 22(4), 382 (2004).
13. Ware CB, Nelson AM, Blau CA: Controlled-rate freezing of hESC. Biotechniques 38(6), 879-880, 882-883 (2005).
14. Hasegawa K, Fujioka T, Nakamura Y, Nakatsuji N, Suemori H: A method for the selection of human embryonic stem cell sublines with high replating efficiency after single-cell dissociation. Stem Cells 24(12), 2649-2660 (2006).
15. ® with hESCs. (Pubitemid 351438945)
16. Li X, Krawetz R, Liu S, Meng G, Rancourt DE: ROCK inhibitor improves survival of cryopreserved serum/feeder-free single human embryonic stem cells. Hum. Reprod. 24(3), 580-589 (2009).
17. Lin T, Ambasudhan R, Yuan X et al.: A chemical platform for improved induction of human iPSCs. Nat. Methods 6(11), 805-808 (2009).
18. Amit M, Carpenter MK, Inokuma MS et al.: Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227(2), 271-278 (2000).
19. Pyle AD, Lock LF, Donovan PJ: Neurotrophins mediate human embryonic stem cell survival. Nat. Biotechnol. 24(3), 344-350 (2006). ••First report describing factors that improve the cloning efficiency of hESCs.
20. Watanabe K, Ueno M, Kamiya D et al.: A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 25(6), 681-686 (2007). ••First report describing use of Rho-associated coiled-coil kinase (ROCK) inhibitors with hESCs.
21. Martin-Ibanez R, Unger C, Stromberg A, Baker D, Canals J, Hovatta O: Novel cryopreservation method for dissociated human embryonic stem cells in the presence of a ROCK inhibitor. Hum. Reprod. 23(12), 2744-2754 (2008). ••First report showing that ROCK inhibitors improve recovery of cryopreserved hESCs.
22. Reubinoff BE, Pera MF, Vajta G, Trounson AO: Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum. Reprod. 16(10), 2187-2194 (2001).
23. Fujioka T, Yasuchika K, Nakamura Y, Naktsuju N, Suemori H: A simple and efficient cryopreservation method for primate embryonic stem cells. Int. J. Dev. Biol. 48(10), 1149-1154 (2009).
24. Li T, Zhou C, Liu C, Mai Q, Zhuang G: Bulk vitrification of human embryonic stem cells. Human Reprod. 23(2), 358-364 (2008).
25. Claassen DA, Desler MM, Rizzino A: ROCK inhibition enhances the recovery and growth of cryopreserved human embryonic stem cells and human induced pluripotent stem cells. Mol. Reprod. Dev. 76(8), 722-732 (2009). ••First report showing that ROCK inhibitors improve recovery of cryopreserved human induced pluripotent stem cells.
26. Takehara T, Teramura T, Onodera Y et al.: Rho-associated kinase inhibitor Y-27632 promotes survival of cynomolgus monkey embryonic stem cells. Mol. Human Reprod. 14(11), 627-634 (2008).
27. Harb N, Archer TK, Sato N: The Rho-ROCK-myosin signaling axis determines cell-cell integrity of self-renewing pluripotent stem cells. PLoS ONE 3(8), e3001 (2008).
28. Ludwig TE, Bergendahl V, Levenstein ME, Yu J, Probasco MD, Thomson JA: Feeder-independent culture of human embryonic stem cells. Nat. Methods 3(8), 637-646 (2006).
29. Kehoe DE, Jing D, Lock LT, Tzanakakis EM: Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng. Part A 16(2), 405-421 (2010).
30. Krawetz R, Taiani JT, Liu S et al.: Large-scale expansion of pluripotent human embryonic stem cells in stirred suspension bioreactors. Tissue Eng. Part C 16(4), 573-582 (2010).
31. Cortes JL, Sanchez L, Ligero G et al.: Mesenchymal stem cells facilitate the derivation of human embryonic stem cells from cryopreserved poor-quality embryos. Hum. Reprod. 24(8), 1844-1851 (2009).
32. Taei A, Gourabi H, Seifinejad A et al.: Derivation of new human embryonic stem cell lines from preimplantation genetic screening and diagnosis-analyzed embryos. In vitro Cell Dev. Biol. Anim. 46 (3-4), 395-402 (2010).
33. Yoshida Y, Takahashi K, Okita K, Ichisaka T, Yamanaka S: Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5(3), 237-241 (2009).
34. Westfall SD, Sachdev S, Das P et al.: Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells. Stem Cells Dev. 17(5), 869-881 (2008).
35. Forristal CE, Wright KL, Hanley NA, Oreffo RO, Houghton FD: Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions. Reproduction 139(1), 85-97 (2010).
36. Esteban MA, Wang T, Qin B et al.: Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6(1), 71-79 (2010).
37. Park IH, Zhao R, West JA et al.: Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451(7175), 141-146 (2008).
38. Koyanagi M, Takahashi J, Arakawa Y et al.: Inhibition of the Rho/ROCK pathway reduces apoptosis during transplantation of embryonic stem cell-derived neural precursors. J. Neurosci. Res. 86(2), 270-280 (2008).